Dare Bioscience, Inc. Amortization of Debt Issuance Costs and Discounts
Dare Bioscience, Inc. (DARE) reported Amortization of Debt Issuance Costs and Discounts of $610.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2017-08-14
- Dare Bioscience, Inc. amortization of debt issuance costs and discounts for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. amortization of debt issuance costs and discounts for the quarter ending 2017-03-31 was $610.00K, a 380.31% increase year-over-year.
- Dare Bioscience, Inc. amortization of debt issuance costs and discounts for the quarter ending 2016-12-31 was $85.00K.
- Dare Bioscience, Inc. amortization of debt issuance costs and discounts for the quarter ending 2016-09-30 was $93.00K, a 59.39% decline year-over-year.
- Dare Bioscience, Inc. amortization of debt issuance costs and discounts for fiscal 2016 was $420.00K, a 43.17% decline from fiscal 2015.
- Dare Bioscience, Inc. amortization of debt issuance costs and discounts for fiscal 2015 was $739.00K, a 243.72% increase from fiscal 2014.
- Dare Bioscience, Inc. amortization of debt issuance costs and discounts for fiscal 2014 was $215.00K, a 0.00% change from fiscal 2013.
- Dare Bioscience, Inc. amortization of debt issuance costs and discounts for fiscal 2013 was $215.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $610.00K 10-Q · filed 2017-08-14 | $695.00K derived: sum of 3 quarters · filed 2017-08-14 | $788.00K derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | $610.00K 10-Q · filed 2017-05-12 | $695.00K derived: sum of 2 quarters · filed 2017-06-13 | $788.00K derived: sum of 3 quarters · filed 2017-06-13 | $903.00K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-12-31 | $85.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | $178.00K derived: sum of 2 quarters · filed 2017-06-13 | $293.00K derived: sum of 3 quarters · filed 2017-08-14 | $420.00K 10-K/A · filed 2017-06-13 |
| 2016-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $208.00K derived: sum of 2 quarters · filed 2017-08-14 | $335.00K 10-Q · filed 2016-11-03 | $54.00K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $242.00K 10-Q · filed 2017-08-14 | -$39.00K derived: sum of 3 quarters · filed 2017-08-14 | $190.00K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $127.00K 10-Q · filed 2017-05-12 | -$154.00K derived: sum of 2 quarters · filed 2017-06-13 | $75.00K derived: sum of 3 quarters · filed 2017-06-13 | $351.00K derived: sum of 4 quarters · filed 2017-06-13 |
| 2015-12-31 | -$281.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | -$52.00K derived: sum of 2 quarters · filed 2017-06-13 | $224.00K derived: sum of 3 quarters · filed 2017-06-13 | $739.00K 10-K/A · filed 2017-06-13 |
| 2015-09-30 | $229.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $505.00K derived: sum of 2 quarters · filed 2016-11-03 | $1.02M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $791.00K 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $515.00K 10-Q · filed 2016-05-02 | |||
| 2014-12-31 | $215.00K 10-K/A · filed 2017-06-13 | |||
| 2013-12-31 | $215.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |